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All types of DNA damage cause a local alteration and relaxation of chromatin structure. Sensing and reacting to this
initial chromatin alteration is a necessary trigger for any type of DNA damage response (DDR). In this context, chromatin
kinases are likely candidates to participate in detection and reaction to a locally altered chromatin as a consequence of
DNA damage and, thus, initiate the appropriate cellular response. In this work, we demonstrate that VRK1 is a
nucleosomal chromatin kinase and that its depletion causes loss of histones H3 and H4 acetylation, which are required
for chromatin relaxation, both in basal conditions and after DNA damage, independently of ATM. Moreover, VRK1
directly and stably interacts with histones H2AX and H3 in basal conditions. In response to DNA damage induced by
ionizing radiation, histone H2AX is phosphorylated in Ser139 by VRK1. The phosphorylation of H2AX and the formation
of gH2AX foci induced by ionizing radiation (IR), are prevented by VRK1 depletion and are rescued by kinase-active, but
not kinase-dead, VRK1. In conclusion, we found that VRK1 is a novel chromatin component that reacts to its alterations
and participates very early in DDR, functioning by itself or in cooperation with ATM.
Introduction
The maintenance of genome stability requires several cellular
mechanisms that are able to protect, prevent, detect, and correct
the deleterious consequences of DNA damage. DNA-damage
sensor mechanisms should also be able to react to very different
types of damage. All types of DNA damage have a common ini-
tial effect: they cause a local distortion of chromatin. Following
DNA damage, local chromatin structure has to be reorganized in
order to protect DNA from exonucleases attack and permit the
incorporation of several proteins that are sequentially implicated
in different steps of specific DNA repair processes.1-3 Their initial
access of these proteins to damaged DNA is allowed by histone
acetylation that facilitates chromatin relaxation, 4 access to spe-
cific proteins, 5 and the recruitment of Tip60 6 that acetylates
ATM.7,8 Immediately after DNA damage, there is an early phos-
phorylation of histone H2AX in Ser139 at damage sites.9,10
Phosphorylated H2AX plays a protective role and covers a large
region of 2 megabases surrounding DNA breaks.11,12 This large
area of chromatin containing phosphorylated H2AX functions as
a platform that will form a complex with NBS1,13 and recruits
downstream components such as ATM, a mediator kinase.8,14,15
This local organization leads to the dynamic assembly of DNA
damage response (DDR) complexes, whose components and
functions vary in time as the repair process progresses. In any
organism exposed to DNA damage, the cellular response has to
be handled individually by each cell, independently of its situa-
tion regarding cell cycle phase, including arrested cells, and local
environment. Thus, within a tissue, the same cell type has to han-
dle DNA damage simultaneously in different biological condi-
tions, but with the same aim, its repair.
Chromatin remodeling implicates several types of histone cova-
lent modifications that play different functional roles.16 In this
context, the balance between these modifications are likely to be
regulated by a complex network of signaling pathways that coordi-
nate many different processes and, among them, kinases are likely
to play an important role. It was previously demonstrated that the
nuclear vaccinia-related kinase 1 (VRK1) plays more than one role
in DDR and is implicated in responses to DNA damage induced
by UV-light 17 and ionizing radiation.18 Furthermore, VRK1 is
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known to phosphorylate histone H319 and its kinase activity can
be regulated by its interaction with histones.20,21 Thus, VRK1 is a
likely candidate to play a coordinating role of different signaling
pathways in mammalian DNA damage response.
The VRK family appeared late in evolution and is not present
in yeasts, has one member in invertebrates, C. elegans and D. mela-
nogaster, and has 3 members in vertebrates.22 Analysis of VRK1
expression has revealed that it is associated to cell cycle and chro-
matin remodeling biological processes.23 VRK1 is one of the most
abundant kinases within nuclei of human cells.24 Several processes
implicating, or requiring, chromatin remodeling have been associ-
ated to VRK1. Among them, VRK1 phosphorylates histone
H3,19 and its kinase activity is regulated by interaction of the C-
terminus with histones20,21 and other proteins.25 In addition,
VRK1 promotes removal of heterochromatin protein 1 (HP1), 19
facilitating the activation of ATM in DNA repair.6,26 Also, the
interaction of VRK1 with heterogeneous nuclear ribonucleopro-
tein A1 (hnRNP-A1) 27 functions as an RPA displacement factor
in telomeres.28 Furthermore, VRK1 phosphorylates BAF, which
links chromatin to the nuclear envelope.29,30 Pathologically,
human VRK1 mutations are very rare and are manifested as com-
plex neurodegenerative syndromes in children, in which pontocer-
ebellar hypoplasia, microcephaly, muscular atrophy, and ataxia are
components of their clinical phenotype.31,32 Similarly, many
hereditary mutations in DNA repair genes are also clinically mani-
fested as neurodegenerative diseases in children.33
Gene transcription requires dynamic local remodeling of chro-
matin. In this context of chromatin-associated processes, VRK1
can also form stable complexes with several transcription factors,
which are another type of chromatin components. VRK1 forms a
basal complex with p53,17 which is phosphorylated in Thr18 34,35
in response to DNA damage and switches its binding mode from
ubiquitin ligases to transcriptional cofactors.36,37 Other transcrip-
tion factors that are specifically phosphorylated by VRK1 include
c-Jun,38 CREB1,39 and ATF2.40 Furthermore, VRK1 is also pres-
ent within Oct4 chromatin-modifying complexes.41
Based on the type of VRK1 substrates and its association with
histones and transcription factors, we hypothesized that VRK1
might be a protein functionally linking initial chromatin altera-
tions to DDR and, in that way, be an early participant in DDR
signaling pathways. In this work, we have studied the participa-
tion of VRK1 in DNA damage responses, including global chro-
matin acetylation and effects on histone interaction,
phosphorylation and formation of gH2AX foci, which is a very
early event in IR-induced DNA damage.9,42,43
Results
VRK1 depletion alters chromatin acetylation
Access to DNA requires dealing with a compacted chromatin
that has to become accessible. Therefore, initiation of DDR
requires a local chromatin relaxation to allow for recognition of
DNA damage and initiation of the repair process. In this context,
histone acetylation facilitates chromatin relaxation and accessibility
to other proteins,44 for example, by inducing local increase in
transcription or reduction in mitosis,45,46 indicating that covalent
modifications play a complex role in chromatin dynamics.16
Therefore, we initially tested whether VRK1 depletion could affect
the pattern of global histone acetylation.4,47 For this aim, histones
H4 (acetylated in K5, K8, K12, and K16) and H3K14-acetylation
were used as markers because they are required for initiation of
DDR.4 We first determined the effect of VRK1 knockdown on
global H4 acetylation that includes K16 acetylation in ATM¡/¡
cells that are prone to endogenous DNA damage because of its
defective repair response.48,49 ATM¡/¡ cells have a high basal
level of H4 acetylation, reflecting its underlying defective DNA
repair, which was not further increased by IR, and this basal H4
acetylation was lost by VRK1 knockdown (Fig. 1A). Next, we
tested the level of histone acetylation in A549 (ATMC/C) cells.
In these cells there was no detectable basal H4 acetylation because
DNA repair is functional, but the extensive acetylation induced
by IR was also prevented by VRK1 depletion (Fig. 1B). A
similar effect was observed on H3-K14-acetylation that is
required for ATM activation,50 and which was also induced
by IR and prevented by VRK1 depletion (Fig. S1). The effect
of VRK1 depletion resulted in loss of histone acetylation
independently of cell type (Fig. 1). It is likely that that the
effect of VRK1 is global and could affect several histones
simultaneously. Therefore, VRK1 was depleted in HT144
cells, which have a high basal level of acetylation, and the
effect of VRK1 depletion on the acetylation of several lysine
residues in 3 histones was determined by immunoblotting
analysis. Depletion of VRK1 in HT144 (ATM¡/¡) cells
resulted in loss of histones H2A-K5ac, H3-K14ac and H4-
(K5, K8, K12, K16)ac, and H4-K16ac (Fig. 1C); the latter is
a key regulatory modification controlling chromatin struc-
ture.51 Taking all together, these results indicated that VRK1
is required for global changes in histones acetylation that
occur after DNA damage and that VRK1 facilitates histones
acetylation in an ATM-independent manner.
VRK1 stably interacts with and phosphorylates histone
H2AX
DNA damage sensor mechanisms require being in direct contact
with chromatin proteins. Therefore, to establish the presence of
VRK1 in chromatin, nuclei were isolated from cells, low and high-
salt protein fractions were prepared, and the effect of VRK1 knock-
down on them was determined. VRK1 was mostly present in the
high-salt resistant chromatin fraction, but it was not required for
histone maintenance because VRK1 knockdown did not release
histones H3 and H2AX from chromatin (Fig. 2A). The consequen-
ces of VRK1 depletion on chromatin changes are not the release of
histones from chromatin, since histones remain bound to chroma-
tin after VRK1 depletion. Alternatively, VRK1 can function by reg-
ulating the covalent modifications of histones that underlie
chromatin remodeling. This role is consistent with the effects of
VRK1 knockdown on acetylation described in the previous section.
To determine whether VRK1 can form stable complexes with
nucleosomal histones, VRK1 was immunoprecipitated from
nuclear extracts and the presence of histones H2AX (Fig. 2B,
left) and H3 (Fig. 2B, right) determined. In these experiments,
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H3 was used as positive
control.19 Both histones
were detected in the VRK1
immunoprecipitate
(Fig. 2B). These results
indicated that VRK1 could
form a basal stable complex
with these 2 nucleosomal
histones in the absence of DNA damage. Next, we determined
whether these histones, H2AX and H3, could be directly phos-
phorylated by VRK1. For this aim, histones H2AX and H3 were
directly phosphorylated by VRK1 in an in vitro radioactive kinase
assay (Fig. 2C). In addition, the residues phosphorylated in each
histone were identified using phospho-specific antibodies
(Fig. 2D). VRK1 in vitro phosphorylated H2AX in Ser139
(gH2AX) (Fig. 2D, top) and H3 in Thr3 (Fig. 2D, bottom); the
latter was used as positive control. The phosphorylation of
H2AX in Ser139 was also confirmed by in vitro kinase assays
using endogenous VRK1 protein immunoprecipitated from
A549 cells (Fig. 2E) and incubated with human recombinant
Figure 1. VRK1 depletion
reduces histone acetylation.
(A) Effect of VRK1 knockdown
and ionizing radiation on H4K
(5, 8, 12,16) acetylation in
HT144 (ATM¡/¡) cells. VRK1
was knocked-down in HT144
melanoma cells and histone
acetylation was determined
by confocal immunoﬂuores-
cence. At the bottom is
shown the relative ﬂuores-
cence level in arbitrary units
(a.u.), and the level of proteins
in a Western blot. siCt: si-Con-
trol. siV-02: si-VRK1-02. (B)
Effect of VRK1 knockdown
and IR on H4 global acetyla-
tion in A549 (ATMC/C) cells.
VRK1 was knocked-down in
A549 lung cancer cells and
histone H4K(5, 8, 12, 16) acet-
ylation was determined by
confocal immunoﬂuores-
cence. At the bottom, the rel-
ative ﬂuorescence level in
arbitrary units (a.u.) and the
level of proteins in immuno-
blots are shown. siCt: si-Con-
trol. siV-02: si-VRK1-02. (C)
Effect of VRK1 knockdown on
3 different nucleosomal histo-
nes that includes acetylated
histone H2A-K5ac, H3K14ac,
H4K(5,8,12,16)ac and
H4K16ac in HT144 (ATM¡/¡)
cells. Histones were acid
extracted and protein levels
determined with speciﬁc anti-
bodies. All experiments were
performed at least 3 times
and the number of cells
counted from each experi-
ment is the same and where
analyzed by ANOVA test.
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histone proteins. The stoichiometry of the in vitro results sug-
gested that these phosphorylations are also likely to occur in vivo,
since the formation of a stable complex indicates a relatively
much higher local concentration of both proteins within cells.
Ionizing radiation
induces VRK1 activation
and phosphorylation of
histone H2AX
Because VRK1 kinase
is activated by DNA
damage,17,18 we observed
that in irradiated cells
there was also an increase
in the kinase activity of
endogenous VRK1 lead-
ing to increased gH2AX
(Fig. 3A, left) and phos-
pho-H3 levels (Fig. 3A,
right). The specific phos-
phorylation of H2AX in
Ser139 by VRK1 was
confirmed by knockdown
of VRK1, which resulted
in a reduction of gH2AX
induced by IR (Fig. 3B).
We concluded that
VRK1 stably associates
with histones H2AX and
H3, and it is also able to
specifically phosphorylate
them, which indicates
that VRK1 can play an
early role in chromatin
remodeling and DDR.
VRK1 is required for
the formation of gH2AX
foci induced by ionizing
radiation
The role of VRK1 in
chromatin dynamics is
likely to affect compo-
nents in DDR pathways.
Since the formation of
gH2AX foci is the ear-
liest manifestation of
DDR9,12 we studied if
these early foci can be reg-
ulated by VRK1. Initially,
we determined the dose
and time required by IR
to induce gH2AX foci,
which were optimally
detected after 30 min
with a dose of 3Gy
(Fig. S2 A and B). To
study the consequence of VRK1 on H2AX, we determined the
effect of VRK1 knockdown on the formation of gH2AX foci
induced by IR. Depletion of VRK1 resulted in a significant
reduction of gH2AX foci induced by IR (Fig. 4A, Fig. S3), but
Figure 2. VRK1 is a chromatin kinase that stably interacts with and phosphorylates histones. (A) VRK1 is present in
chromatin. Nuclei from A549 cells treated with si-Control (si-Ct) or siVRK1-02 were isolated and fractionated by salt
extraction to separate proteins bound to chromatin. The proteins present in each fraction, cytosol, nuclear soluble,
and chromatin were identiﬁed in western blots with speciﬁc antibodies. GARS was used as cytosolic marker. (B) VRK1
interaction with histones H3 and H2AX. Nuclear lysate was immunoprecipitated with either antibody control (IgG) or
mAb 1F6 that is speciﬁc for human VRK1. In the VRK1 immunoprecipitate endogenous histones H2AX and H3 were
detected. (C) Phosphorylation of histones H2AX and H3 by VRK1. Bacterially expressed and puriﬁed GST-VRK1 protein
was used in an in vitro radioactive kinase assay using 1 mg of recombinants human H2AX and H3 as substrates. H3 was
used as positive control. Top: incorporation of radioactivity. Bottom: proteins present in the assays. (D) Identiﬁcation of
histone residues phosphorylated in histones by VRK1. H2AX (top) and H3 (bottom) were phosphorylated in vitro with
GST-VRK1, and histone phosphorylation was detected with phospho-speciﬁc antibodies. (E) Endogenous VRK1 phos-
phorylates H2AX in Ser139. Kinase assays were performed with endogenous VRK1 that was immunoprecipitated from
293T cells. Puriﬁed human histone H2AX (Millipore) (1 mg) was used as substrate. The kinase activity was determined
in an in vitro kinase assay and speciﬁc phosphorylation of H2AX on Ser139 was detected with a phospho-speciﬁc
antibody.
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foci formation was not
affected in controls. This
effect on gH2AX foci
affected both their number
and size (Fig. 4A graphs).
These results were also
obtained using 2 additional
siRNAs (Fig. S4). Knock-
down of VRK1 also resulted
in defective formation of
gH2AX foci in H1299
(p53¡/¡) cells (Fig. S5) and
HEK293T cells (Fig. S6).
VRK1 knockdown also
affected the activation of
ATM that was detected by
loss of its activating phos-
phorylation in Ser1981
(Fig. 4B). Therefore, we
concluded that the effect of
VRK1 on gH2AX foci is
common to different cell
types and independent of
p53.
VRK1 depletion on gH2AX foci formation also is functional
in cell cycle arrested cells
It is likely that the response to DNA damage may be different
depending on the cell cycle situation. In normal tissues many
cells are non-dividing as is the case for stem cells (normal or
tumoral) or other cell types, such as neurons. Therefore, DNA
damage has to be repaired independently of cell division in all of
them. Because depletion of VRK1 also causes a cell cycle
arrest,18,52,53 it is necessary to rule out that the effect of VRK1
knockdown is not indirect and due to its effect on cell cycle
arrest. Therefore, we tested if the effect of VRK1 depletion on
gH2AX foci was also occurring in cells that were arrested by
serum deprivation. In arrested cells, the formation of gH2AX
foci were induced by IR, like in cycling cells, and these foci were
also lost in arrested cells by VRK1 depletion (Fig. 5). These
results indicated that the role of VRK1 in the initial response to
locally altered chromatin induced by IR is functional in cells
independently of their cell cycle state, which was consistent with
a similar observation on the formation of 53BP1 foci induced by
IR.18,54
Kinase-active, but not kinase-dead, VRK1 rescues gH2AX
foci induced by IR
To establish whether the kinase activity of VRK1 is necessary
to form gH2AX foci induced by IR, rescue experiments were per-
formed using VRK1 constructs that are resistant (R) to knock-
down with siVRK1-01 and expressing either a kinase active
VRK1 (VRK1-R) or a kinase inactiveVRK1 (VRK1-R-KD) pro-
tein. After depletion of the endogenous VRK1, cells were trans-
fected with the appropriate resistant VRK1 plasmid and the
formation of gH2AX foci induced by IR was determined.
Control cells formed foci in response to IR (Fig. 6, top panel).
Following endogenous VRK1 knockdown, only those cells
expressing kinase-active VRK1 that is resistant to siRNA (VRK1-
R)(Fig. 6A, middle panel) were able to rescue the formation of
gH2AX foci induced by IR. In contrast, cells expressing kinase-
dead VRK1 and resistant to siRNA (VRK1-R-KD) did not rescue
gH2AX foci (Fig. 6A, bottom panel). We concluded that the
kinase activity of VRK1 is necessary for formation of gH2AX
foci induced by IR.
VRK1 effect on gH2AX foci is insensitive to KU55933 and
PI3K inhibitors
VRK1 is insensitive to known kinase inhibitors targeting all
kinases families in the kinome 55 and has a very low promiscuity
(cross inhibitory) index, 56 making it a potential target for highly
specific inhibitors. Several kinases participating in DDR are
members of the PI3K family. Inhibitors of PI3K such as caf-
feine,57 which does not inhibit VRK1,35 and KU55933, which
specifically inhibits ATM 58 but not VRK1,55 were tested on
gH2AX foci induced by IR. Each inhibitor by itself was able to
reduce formation of gH2AX foci induced by IR, consistent with
the known role of ATM in DDR signaling.59,60 However, knock-
down of VRK1 by itself was also able to reduce gH2AX foci to a
similar extent, and this reduction was further enhanced when
used in combination with KU55933 or caffeine (Fig. 6B,
Fig. S7A), indicating that they have an additive effect (Fig. 6B,
graph). This additive effect may be due to blocking the remain-
ing signal that is allowed by the reduced VRK1 level. The
KU55933 inhibitor (at a 100 mM concentration) had no effect
on VRK1 kinase activity (Fig. S7B). These data indicated that
VRK1 and ATM could contribute to gH2AX foci formation,
probably acting at different levels and cooperating in foci
formation.
Figure 3. Effect of ionizing radiation on histone phosphorylation. (A) Endogenous VRK1 activated by IR phosphory-
lates H2AX (left panel) and H3 (right panel). Endogenous VRK1 was immunoprecipitated from A549 or MCF-7 cells.
A control immunoprecipitation was carried out with aAU5 antibody. The immunoprecipitated VRK1 was used in an
in vitro kinase assay using as substrate recombinant H2AX (left) or H3 (right). (B) Speciﬁty of H2AX phosphorylation
by VRK1 induced by IR. To demonstrate the speciﬁty of H2AX phosphorylation, A549 cells were transfected with
siRNA control (siCt) or siRNA for VRK1 (siV1-02).VRK1 was immunoprecipitated and used in a kinase assay. Expres-
sion of VRK1 is shown at the bottom and gH2AX phosphorylation was evaluated by immunoblots after histone
acidic extraction with a phospho-speciﬁc antibody.
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Discussion
In this report, we have
shown that VRK1 is a
Ser-Thr kinase resident
on chromatin that has
important consequences
on histone covalent modi-
fications that regulate
chromatin organization
(Fig. 7). Alterations in
chromatin regulatory
mechanisms are likely to
have functional conse-
quences on processes that
require dynamic chroma-
tin remodeling. The com-
plex formed between
VRK1 and histones in
basal conditions is impor-
tant because it permits an
immediate response as a
consequence of reacting
to a chromatin distortion
caused by DNA damage,
independently of its type.
In this context, VRK1 can
have 2 different roles.
One is a consequence of
the participation of
VRK1 in chromatin
remodeling processes that
is reflected by its contri-
bution to regulation of
histone covalent modifica-
tions and their different
functional consequences.
The consequences of
VRK1 depletion on chro-
matin are not a conse-
quence of histone release
from chromatin, since his-
tones remain bound to
chromatin. But VRK1
depletion has a profound
effect on chromatin cova-
lent modifications, such
as global histone acetyla-
tion, a histone modifica-
tion that has a complex
role in chromatin dynam-
ics.16 This VRK1 effect
on global histone acetyla-
tion is also independent
of ATM, an early media-
tor kinase in DDR, since
Figure 4. VRK1 is required for gH2AX foci induced by IR. (A) Effect of VRK1 knockdown (si-VRK1) on gH2AX foci in A549
cells, compared or si-Control. VRK1 detection by immunoblot is at the bottom. Number of foci were analyzed by
immunoﬂuorescence confocal microscopy, counted, and represented in the graph (at the top) while the ﬂuorescence
of individual foci is shown in the graph (bottom). H2AX phosphorylation in immunoﬂuorescence was determined
using a gH2AX phospho-speciﬁc antibody. (B) Effect of VRK1 knockdown on ATM activation by IR. The phosphorylation
of ATM in Ser1981 was determined in A549 cells by protein gel blot using a phospho-speciﬁc antibody. All experi-
ments were performed at least 3 times and the number of cells counted from each experiment is the same and where
analyzed by ANOVA test.
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it is also detected in ATM
null cells. Thus, the effect
on H3K9 acetylation can
have important conse-
quences since it affects
interactions with HP1 and
Polycomb.61
The role of VRK1 in
chromatin is also sup-
ported by its participation
in transcriptionally active
chromatin, which is also
acetylated and in a more
open conformation. In this
context, VRK1 is able to
form stable protein com-
plexes with several tran-
scription factors 17,35,38-40
and acetyl transferases,62,63
since transcription also
requires a dynamic remod-
eling of local chromatin.
VRK1 contribution to
DDR can be mediated by
2 main types of mecha-
nisms. The first is a conse-
quence of altering the local
chromatin structure in
such a way that the repair
process cannot be initiated
or, alternatively, down-
stream repair processes fail
at the same stage due to a
chromatin dynamics prob-
lem. VRK1, in addition to
this general role on chro-
matin, can also contribute to DDR by participating in the regula-
tion of specific steps in DDR pathway components. The direct
phosphorylation of H2AX in Ser139 and formation of gH2AX
foci is an example of a specific and early role. In addition, VRK1
can also participate with a specific role in the regulation of addi-
tional downstream components in a specific DDR pathway, such
as the regulation of 53BP1. IR induces an interaction between
VRK1 and 53BP1 that is specifically phosphorylated in Ser25,
and VRK1 depletion also impairs formation of 53BP1 foci.18
Alternatively, and in response to a common type of DNA dam-
age, such as double-strand breaks in which 2 different pathways
are functional NHEJ and HR, it is unknown if VRK1 partici-
pates in their selection, or whether this selection is independent
of the permissive role that VRK1 plays. Thus, the specific partici-
pation of VRK1 in alternative or different DDR pathways and
their components is a likely possibility that will require further
studies, since chromatin remodeling and DDR are intertwined
processes.
The role of VRK1 in DDR suggests that its pharmacological
targeting is likely to make cells more sensitive to drugs whose
mechanism of action is based on DNA damage. Such an effect
has already been identified in response to doxorubicin.54 Alterna-
tively, high VRK1 levels should make cells more resistant to
treatment, and this has been reported in breast cancer, 54 in
which VRK1 identifies a subgroup within estrogen receptor posi-
tive cases that presents a poorer prognosis.64,65 The structure of
VRK1 indicates that any specific inhibitor will have no cross-
inhibitory effect on other kinases due its very low promiscuity
index55,56 and, therefore, makes VRK1 a very good candidate for
development of highly specific inhibitors that may be useful in
treatment of some tumors.
In conclusion, we propose and provide evidence for an
important role of VRK1 on covalent modifications of histo-
nes, and thus it can regulate cellular processes requiring a
dynamic remodeling of chromatin. In this context, VRK1
can play different roles due of its participation in chromatin
remodeling that is reflected by its contribution to histone
covalent modifications and its different functional conse-
quences. The implication of VRK1 in chromatin regulation
opens up several, and different, issues for future work.
Figure 5. Effect of VRK1 depletion on gH2AX foci formation in serum deprived cells. VRK1 was knocked down in A549
cells that were serum deprived for 2 d Cells were irradiated and the formation of gH2AX foci determined by confocal
immunoﬂuorescence. In the blot is shown the effect of the levels of phospho-Rb determined by western blot. All
experiments were performed at least 3 times and the number of cells counted from each experiment is the same
and where analyzed by ANOVA test.
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Among them is the role
of VRK1 on histones,
their different covalent
modifications, and their
coordination in time and
space as a function of
the biological effect. Fur-
thermore, there might
also be differences
among euchromatin and
heterochromatin that can
be affected by their
dynamic changes occur-
ring in transcription, dif-
ferentiation, replication,
recombination, DDR,
and cell cycle progres-
sion. Therefore, multiple
chromatin-associated
processes are likely can-
didates to be regulated
by VRK1, and these will
require further specific
studies.
Material and Methods
Full methods in
supplementary file
Plasmids
VRK1 protein was
expressed in E. coli BL21
strain from plasmid
pGEX4T-GST-VRK1 and
expressed and purified as
previously reported34
Mammalian expression
plasmid p-CEFL-HA-
VRK1,35,63 plasmid p-
CEFL-HA-VRK1(R391/
R393/V394) and resistant
to si-VRK1-01 were previ-
ously described.18 Kinase-
dead VRK1 was made by
introducing the K179E
mutation in the catalytic
site by site-directed
mutagenesis.18
Cell lines, culture, and
transfections
A549, H1299 (p53¡/
¡), HEK-293T, MCF7
and HT144 (ATM¡/¡)
Figure 6. VRK1 activity is required for gH2AX foci formation. (A) Active VRK1 resistant to siRNA rescues formation of
gH2AX foci. Endogenous VRK1 in A549 cells was knocked-down with siVRK1-01 followed 2 d later by transfection with
a plasmid expressing HA-VRK1-R (with 3 substitutions that make it resistant only to si-VRK1-01)18 (VRK1-R in the ﬁgure)
or its kinase-dead form (VRK1-R-KD in the ﬁgure). Cells were analyzed by immunoﬂuorescence confocal microscopy.
The number of foci in cells was counted and signiﬁcance determined using ANOVA analysis. (B) Effect of inhibitors
KU55933 and caffeine on gH2AX foci formation. A549 cells were treated with si-Control or si-VRK1-02 and the effect of
KU55933 and caffeine on gH2AX foci induced by IR determined. The number of gH2AX foci was quantiﬁed.
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validated cell lines were from the ATCC, and were grown as rec-
ommended by the supplier. Cell lines were free of mycoplasma.
Plasmid transfections were performed using the Jet-Pei reagent
(Polytransfection Plus, Illkirch, France), as reported.63
RNA interference
Specific silencing of VRK1 was performed using different
siRNA: siVRK1-01 (siV1-01), siVRK1-02 (siV1-02), siVRK1-
03 (siV1-03), and siVRK1-09 (siV1-09) from Dharmacon. As
negative control, the “ON-TARGETplus siControl Non-target-
ing siRNA” (siCt) from Dharmacon was used, as previously
reported.18 In rescue experiments, cells that were transfected with
the siRNA were re-transfected 36 h later with plasmids express-
ing a si-resistant mutant of VRK1.18
Kinase assays
In vitro kinase assays using either bacterially purified GST-
VRK1, immunoprecipitated endogenous VRK1, or transfected
HA-VRK1 from plasmid pCEFL-HA-VRK1 were performed as
previously reported 18 and indicated in specific experiments. In
vitro kinase assays with purified proteins contained 1 mg of each
GST-VRK1 and histones (H3 or H2AX), which is equivalent,
on a molar base, to 1 molcule of kinase per 8 molcules of histones
(2 nucleosomes).
Antibodies
VRK1 was detected with VC166 or HPA00066 (Sigma) poly-
clonal antibodies; or 1F6 or 1B5 mAb.66 H2AX (BL552, Bethyl
or 2,595, Cell Signaling). Phosphorylated H2AX in Ser139
(Ab2577, Cell Signaling). Histone H3, polyclonal antibody
(Ab9715, Cell Signaling). H3T3P (07-424, Upstate). Histone
H4(K5, K8, K12, K16)Ac (Ab 06-866, Upstate). Histone
H3K14Ac (Ab 06-911, Upstate). Histone H4(K16)Ac
(Ab109463, abcam). 53BP1 (mAb BP13, Upstate; or Ab
H300, Santa Cruz). ATM (PC116, Calbiochem). Phosphory-
lation of ATM in Ser1981 (mAb 10H11.E12, Calbiochem).
Retinoblastoma/Rb (Ab sc-50, Santa Cruz). Phospho-Rb
(Ser807/811) (Ab9308 Cell Signaling). b-actin mAb clone
AC-15 (Sigma). Goat anti-rabbit IgG-Cy2 and goat anti-
mouse IgG-Cy3 (Jackson laboratory, West Grove, PA). Goat
anti-mouse IgG- Cy2 and goat anti-rabbit IgG-Cy 3 (Amer-
sham). Immunoblots were performed as previously reported.18
Immunoblot fluorescence was detected in an Odyssey reader
(Li-Cor).
Subcellular fractionation and acidic extraction of histones
A549 cells were lysed with Cytoplasmic fraction Buffer
(10 mM HEPES pH 7.6; 3 mM MgCl2; 40 mM KCl; 5%
Glycerol; 0.5% NP40) and nuclei were pelleted by centrifugation
at 1,250 g at 4C for 5 min. The supernatant containing the
cytoplasmic fraction was confirmed by detection of GARS as
cytoplasmic marker. The nuclear pellet was washed and resus-
pended in nuclear fraction buffer (10 mM HEPES pH 7.9;
1.5 mM MgCl2; 0.1 mM EGTA; 25% Glycerol; 420 mM
NaCl), and incubated for 20 min on ice. Following a centrifuga-
tion at 1,250 g at 4C to eliminate the nuclear membranes, the
supernatant contained the nuclear proteins. Histones were acid
extracted as published.67
Immunofluorescence and confocal microscopy
Immunofluorescence methodology has been previously
reported.18 Nuclei were stained with DAPI. Images were
obtained with a LEICA TCS SP5 DMI-6000B confocal
microscope (Leica). Images were analyzed with LEICA
LAS AF (Leica) and ImageJ (http://rsb.info.nih.gov/ij) soft-
ware. Microscope settings are indicated in supplementary
methods.
Statistical analysis
Quantitative experiments were performed at least 3 times,
the number of cells is indicated, and statistical analysis was
performed by the ANOVA 2-way test using the IBM SPSS
21 statistics package. Results are presented as box plots with
the median, first and third quartiles and standard
deviations.68
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Figure 7. Effect of VRK1 depletion on histone covalent modiﬁcations.
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